Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recruiting across multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Head and Neck Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Soft Tissue Sarcoma
• Triple-negative Breast Cancer

Drugs mentioned

• ILB2109
• Toripalimab (Toripalimab)

Snippet

Sponsor: Innolake Biopharm | Conditions: Head and Neck Cancer, Cervical Cancer | Phase 1, Phase 2 | Status: RECRUITING